Brain metastases are a common problem in patients with EGFR-mutated non-small cell lung cancer (NSCLC), occurring in about one-fifth to one-quarter of patients. Many brain metastases will be ...

Once non-small-cell lung cancer (NSCLC ... drug necitumumab (Portrazza). The brain, bones, and areas around the lungs are the most common places this cancer spreads. You'll get specific care ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Zongertinib shows promise for treating HER2-mutant non–small cell lung cancer (NSCLC), with significant activity against brain metastases and low interstitial lung disease risk, explains John Heymach, ...

Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer ...

Scoping Review of the Impact of Culture on the Effectiveness of Quality Improvement Programs CNS metastases (CNSms ... The most frequent primary cancer sites were the breast (34%, n = 281), lung (26%, ...

Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises ...

Scientists Discover That Special Immune Cells Stop Metastatic Cancer Oct ... Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4, 2024 — The University of ...

Researchers reveal a strategy that helps medulloblastoma, the most prevalent malignant brain tumor in children, spread and grow on the leptomeninges, the membranes surrounding the brain and spinal ...

Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths after lung cancer.